Why I'm not buying Woolworths Limited shares

I'm not a big fan of Woolworths Limited (ASX:WOW) at today's share price.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The big supermarket operators like Woolworths Limited (ASX: WOW) and Wesfarmers Ltd (ASX: WES) sometimes seem like a natural place to invest. They are strong businesses, pay reliable dividends, and have at least some competitive advantages.

Still I'm not a buyer today, for 2 primary reasons:

  • Competition

Woolworths, Coles, Aldi, Metcash Limited (ASX: MTS), plus some other operators like Lidl and Costco are competing for a pie that is growing relatively slowly. Plus, Australia has historically had higher grocery margins compared to some international markets, so pricing pressure on margins will likely remain high – potentially hurting profits.

  • Limited growth

While certain categories of food such as gluten-free or precooked might be growing rapidly, it does not appear that the market for supermarket products is growing rapidly. So, the size of the 'pie' for which these stores compete is not becoming much larger. Additionally, while volumes might be rising, the % of profit earned on these sales could be falling, due to the above competitive pressures.

  • Divestments

Woolworths in particular is talking about divesting its petrol stations and possibly also its Dan Murphy's liquor business. While these transactions may unlock value for shareholders, it will also result in selling a business that's contributing to earnings and it is unclear what new prospects could replace these.

Still, if I'm wary of investing in the supermarkets, I'm even more wary of investing in companies that sell their products in a supermarket. Low cost own-brand products are being rolled out in every category from snacks to paracetamol. Which is great, until you look at home brand paracetamol that costs 1/8th the price of Panadol and think about what could happen to the profits of the company that makes Panadol.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »